Delivery Order SPE2DB22D3102-SPE2DB24FL0FU

Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184900 - PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $1,215.60 award has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,231.42 to provide PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract, valued at $1,735.56, is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp has also been awarded an indefinite delivery contract (IDC) by DLA with a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,807.64 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of July 12, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $1,290.24 for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This is a firm fixed price contract with a performance period through March 14, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a standalone delivery order and not part of a larger contract...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,156.42 to Amerisourcebergen Drug Corp's Corporate Office division for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,597.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,968.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563454535 ! PROCTOFOAM-HC 1%-1% FOAM 10GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not hold any set-aside designations. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,752.15 contract is for the provision of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The award has a potential value of $1,114.30 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL0FU
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The $2,431.20 delivery order has a completion date of March 4, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/31/24, 10:44 AM